|[September 23, 2013]
Elekta Opens Global Education Center for Oncology and Neuroscience Professionals
ATLANTA --(Business Wire)--
Elekta (STO:EKTAB) will unveil a state-of-the-art learning center at its
North American headquarters, in conjunction with the 55th Annual Meeting
of the American Society for Radiation Oncology (ASTRO) being held in
The Learning and Innovation Center (LINC) is expected to draw
clinicians, researchers and health IT professionals to the city for
education, training and collaboration on Elekta's industry-leading
solutions for treating cancer and brain disorders. The LINC also serves
as a tangible introduction to Elekta, with interactive displays
highlighting the company's achievements in cancer treatment.
"The creation of the LINC consolidates a wealth of educational resources
that encompass all of our cancer management competencies," says Jay
Hoey, Executive Vice President, Region North America. "Atlanta is an
ideal location for this, with easy airport access to North America and
the world, a thriving metropolitan area and a wealth of other health
care and educational resources."
The 25,000 square foot facility, set among a park-like setting,
incorporates the latest adult learning principles and technology, and is
equipped with actual working systems of virtually every Elekta solution
to support hands-on learning. These solutions represent Elekta's
oncology, sftware, brachytherapy, neuroscience and imaging products,
including the new Versa HD™ linear accelerator and Leksell Gamma Knife®
Perfexion™. Enhancing the experience, students have access to the Versa
HD vault, which is large enough for hands-on learning.
"This is a beautiful facility that brings numerous benefits to Atlanta
and the State of Georgia," says David Hartnett, Vice President, Economic
Development, Bioscience-Health IT, Metro Atlanta Chamber. "Not only does
it provide an ideal setting for learning, but the LINC has educational
exhibits that demonstrate Elekta's leadership in advancing cancer care.
This facility enhances and solidifies Georgia's leadership position in
the fields of cancer treatment and research."
# # #
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial
Instruments Trading Act. The information was published at 15:00 CET on
September 23, 2013.
Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated, state-of-the-art tools and treatment planning
systems for radiation therapy, radiosurgery and brachytherapy, as well
as workflow enhancing software systems across the spectrum of cancer
care. Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer confidence to
both healthcare providers and patients, Elekta aims to improve, prolong
and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over
6,000 hospitals worldwide. Elekta employs around 3,500 employees
globally. The corporate headquarters is located in Stockholm, Sweden,
and the company is listed on the Nordic Exchange under the ticker EKTAb.
This information was brought to you by Cision http://news.cision.com
[ Back To Technology News's Homepage ]